Joseph Jimenez

Sep 21, 2018

uBiome has appointed Joseph Jimenez to its board of directors to support the firm's new drug discovery and development efforts. Prior to uBiome, Jimenez served as CEO of Novartis, where he focused on leading global businesses while divesting non-core divisions. Jimenez has a track record of business leadership at several companies, including Clorox, ConAgra, and H.J Heiz. In addition to uBiome's board of directors, Jimenez also serves on the boards of Procter & Gamble and General Motors. In addition, he served on the board of directors at Colgate-Palmolive from 2009 to 2015, and at AstraZeneca from 2002 to 2017.

Joseph Jimenez

WHO Approves Abbott Molecular Mpox Assay

Foresight Diagnostics Founders Respond to Roche Lawsuit, Says Claims Asserted in Bad Faith

Participant Health Privacy at Risk From Single-Cell RNA Sequencing Data, Study Suggests

With $40M in Funding, Cancer AI Alliance Aims to Pool Data, Computing Resources to Boost Research

Oncocyte Nets $10.2M in Private Placement, Notes New Customers for Transplant Test